UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans

Pharmacology & therapeutics (Oxford), 2020-07, Vol.211, p.107528-107528, Article 107528

2020

Volltextzugriff (PDF)

Wiping Out CGRP: Potential Cardiovascular Risks

Trends in pharmacological sciences (Regular ed.), 2016-09, Vol.37 (9), p.779-788

2016

Volltextzugriff (PDF)

The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs

Pharmacology & therapeutics (Oxford), 2009-12, Vol.124 (3), p.309-323

2009

Volltextzugriff (PDF)

Basic mechanisms of migraine and its acute treatment

Pharmacology & therapeutics (Oxford), 2012-12, Vol.136 (3), p.319-333

2012

Volltextzugriff (PDF)

Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?

Pharmacology & therapeutics (Oxford), 2018-06, Vol.186, p.88-97

2018

Volltextzugriff (PDF)

CGRP inhibitors for migraine prophylaxis: a safety review

Expert opinion on drug safety, 2020-10, Vol.19 (10), p.1237-1250

2020

Volltextzugriff (PDF)

Gender aspects of CGRP in migraine

Cephalalgia, 2019-03, Vol.39 (3), p.435-444

2019

Volltextzugriff (PDF)

The Role of 5-Hydroxytryptamine in the Pathophysiology of Migraine and its Relevance to the Design of Novel Treatments

Mini reviews in medicinal chemistry, 2017-01, Vol.17 (11), p.928

2017

Volltextzugriff (PDF)

The influence of pharmacodynamics and pharmacokinetics on the antimigraine efficacy and safety of novel anti-CGRPergic pharmacotherapies: a narrative review

Expert opinion on drug metabolism & toxicology, 2024-09, p.1-12

2024

Volltextzugriff (PDF)

Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus

Frontiers in neurology, 2021-06, Vol.12, p.686398-686398

2021

Volltextzugriff (PDF)

5-Hydroxytryptamine and cardiovascular regulation

Trends in pharmacological sciences (Regular ed.), 2008-09, Vol.29 (9), p.472-481

2008

Volltextzugriff (PDF)

Side effects associated with current and prospective antimigraine pharmacotherapies

Expert opinion on drug metabolism & toxicology, 2018-01, Vol.14 (1), p.25-41

2018

Volltextzugriff (PDF)

Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia

Frontiers in public health, 2021-02, Vol.9, p.559595-559595

2021

Volltextzugriff (PDF)

Characterization of binding, functional activity, and contractile responses of the selective 5‐HT1F receptor agonist lasmiditan

British journal of pharmacology, 2019-12, Vol.176 (24), p.4681-4695

2019

Volltextzugriff (PDF)

Pharmacological Nature of the Purinergic P2Y Receptor Subtypes That Participate in the Blood Pressure Changes Produced by ADPβS in Rats

Pharmaceuticals (Basel, Switzerland), 2023-12, Vol.16 (12), p.1683

2023

Volltextzugriff (PDF)

An outlook on the trigeminovascular mechanisms of action and side effects concerns of some potential neuropeptidergic antimigraine therapies

Expert opinion on drug metabolism & toxicology, 2021-02, Vol.17 (2), p.179-199

2021

Volltextzugriff (PDF)

Functional Analysis of TRPA1, TRPM3, and TRPV1 Channels in Human Dermal Arteries and Their Role in Vascular Modulation

Pharmaceuticals (Basel, Switzerland), 2024-01, Vol.17 (2), p.156

2024

Volltextzugriff (PDF)

Pharmacological Profile of the Purinergic P2Y Receptors That Modulate, in Response to ADPβS, the Vasodepressor Sensory CGRPergic Outflow in Pithed Rats

Pharmaceuticals (Basel, Switzerland), 2023-03, Vol.16 (3), p.475

2023

Volltextzugriff (PDF)

The impact of CGRPergic monoclonal antibodies on prophylactic antimigraine therapy and potential adverse events

Expert opinion on drug metabolism & toxicology, 2021-10, Vol.17 (10), p.1223-1235

2021

Volltextzugriff (PDF)

Potential mechanisms of prospective antimigraine drugs: a focus on vascular (side) effects

Pharmacology & therapeutics (Oxford), 2011-03, Vol.129 (3), p.332-351

2011

Volltextzugriff (PDF)

Aminomethylphosphonic Acid (AMPA), a Glyphosate Metabolite, Decreases Plasma Cholinesterase Activity in Rats

Journal of xenobiotics, 2024-05, Vol.14 (2), p.604-612

2024

Volltextzugriff (PDF)

Functional Characterization of the Prejunctional Receptors Mediating the Inhibition by Ergotamine of the Rat Perivascular Sensory Peptidergic Drive

ACS chemical neuroscience, 2019-07, Vol.10 (7), p.3173-3182

2019

Volltextzugriff (PDF)

The locus of Action of CGRPergic Monoclonal Antibodies Against Migraine: Peripheral Over Central Mechanisms

CNS & neurological disorders drug targets, 2020, Vol.19 (5), p.344-359

2020

Volltextzugriff (PDF)

Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery

Cephalalgia, 2011-01, Vol.31 (2), p.181-189

2011

Volltextzugriff (PDF)

A critical review of the neurovascular nature of migraine and the main mechanisms of action of prophylactic antimigraine medications

Expert review of neurotherapeutics, 2021-09, Vol.21 (9), p.1035-1050

2021

Volltextzugriff (PDF)

1 – 25 von 317

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(286)
Mit Volltextzugriff
(288)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(162)
Life Sciences & Biomedicine
(157)
Animals
(132)
Pharmacology & Pharmacy
(116)
Male
(91)
Biological And Medical Sciences
(84)
Humans
(63)
Rats
(62)
Medical Sciences
(61)
Migraine
(51)
Rats, Wistar
(49)
Pharmacology. Drug Treatments
(46)
Dose-Response Relationship, Drug
(44)
Blood Pressure - Drug Effects
(41)
Female
(41)
Heart Rate - Drug Effects
(39)
5-Ht
(36)
Hemodynamics - Drug Effects
(33)
Serotonin Antagonists - Pharmacology
(31)
Migraine Disorders - Drug Therapy
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans

Wiping Out CGRP: Potential Cardiovascular Risks

The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs

Basic mechanisms of migraine and its acute treatment

Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?

CGRP inhibitors for migraine prophylaxis: a safety review

Gender aspects of CGRP in migraine

The Role of 5-Hydroxytryptamine in the Pathophysiology of Migraine and its Relevance to the Design of Novel Treatments

The influence of pharmacodynamics and pharmacokinetics on the antimigraine efficacy and safety of novel anti-CGRPergic pharmacotherapies: a narrative review

Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus

5-Hydroxytryptamine and cardiovascular regulation

Side effects associated with current and prospective antimigraine pharmacotherapies

Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia

Characterization of binding, functional activity, and contractile responses of the selective 5‐HT1F receptor agonist lasmiditan

Pharmacological Nature of the Purinergic P2Y Receptor Subtypes That Participate in the Blood Pressure Changes Produced by ADPβS in Rats

An outlook on the trigeminovascular mechanisms of action and side effects concerns of some potential neuropeptidergic antimigraine therapies

Functional Analysis of TRPA1, TRPM3, and TRPV1 Channels in Human Dermal Arteries and Their Role in Vascular Modulation

Pharmacological Profile of the Purinergic P2Y Receptors That Modulate, in Response to ADPβS, the Vasodepressor Sensory CGRPergic Outflow in Pithed Rats

The impact of CGRPergic monoclonal antibodies on prophylactic antimigraine therapy and potential adverse events

Potential mechanisms of prospective antimigraine drugs: a focus on vascular (side) effects

Aminomethylphosphonic Acid (AMPA), a Glyphosate Metabolite, Decreases Plasma Cholinesterase Activity in Rats

Functional Characterization of the Prejunctional Receptors Mediating the Inhibition by Ergotamine of the Rat Perivascular Sensory Peptidergic Drive

The locus of Action of CGRPergic Monoclonal Antibodies Against Migraine: Peripheral Over Central Mechanisms

Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery

A critical review of the neurovascular nature of migraine and the main mechanisms of action of prophylactic antimigraine medications

Suchergebnisse filtern